CytomX Therapeutics, Inc.
CTMX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $76.2M | $138M | −44.8% |
| Operating income | −$22.4M | $25.0M | |
| Net income | −$20.4M | $31.9M |
Questions
- What was CytomX's revenue in FY2025?
- $76.2M in FY2025 (Fiscal year ended Dec 31, 2025), −44.8% vs $138M a year earlier, per its 10-K filed Mar 2026.
- Was CytomX profitable in FY2025?
- No: net income was −$20.4M and operating income −$22.4M in FY2025.